Connective tissue disease in pregnancy.

Area of Science:

• Rheumatology
• Obstetrics
• Immunology

Background:

• Connective tissue diseases (CTD) are chronic, multisystem disorders, often autoimmune.
• Many CTDs affect women of childbearing age, presenting unique challenges during pregnancy.

Purpose of the Study:

• To review the management of common autoimmune CTDs in pregnant women.
• To highlight key considerations for preconception, pregnancy, and postpartum care.
• To discuss medication safety in this context.

Main Methods:

• Literature review focusing on autoimmune connective tissue diseases and pregnancy.
• Synthesis of current evidence on disease management and medication safety.
• Discussion of multidisciplinary team care and preconception counseling.

Main Results:

• Pregnancy significantly impacts women with CTD, and vice versa.
• Careful medication selection and management are crucial for maternal and fetal outcomes.
• Preconception counseling and a multidisciplinary approach are essential.

Conclusions:

• Optimal obstetric and medical care for pregnant women with autoimmune CTDs relies on understanding disease-specific challenges.
• Knowledge of medication safety and the interplay between CTD and pregnancy is vital.
• Multidisciplinary team care ensures comprehensive management before, during, and after pregnancy.